16.73
price down icon1.47%   -0.2504
 
loading
Precedente Chiudi:
$16.98
Aprire:
$17.08
Volume 24 ore:
112.04K
Relative Volume:
0.20
Capitalizzazione di mercato:
$1.01B
Reddito:
$1.23M
Utile/perdita netta:
$-214.90M
Rapporto P/E:
-4.0584
EPS:
-4.1222
Flusso di cassa netto:
$-151.25M
1 W Prestazione:
+1.46%
1M Prestazione:
+9.92%
6M Prestazione:
-23.61%
1 anno Prestazione:
-44.12%
Intervallo 1D:
Value
$16.43
$17.20
Intervallo di 1 settimana:
Value
$16.43
$18.30
Portata 52W:
Value
$10.91
$40.26

Spyre Therapeutics Inc Stock (SYRE) Company Profile

Name
Nome
Spyre Therapeutics Inc
Name
Telefono
(617) 651-5940
Name
Indirizzo
221 CRESCENT STREET, WALTHAM
Name
Dipendente
65
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
SYRE's Discussions on Twitter

Confronta SYRE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SYRE
Spyre Therapeutics Inc
16.71 1.07B 1.23M -214.90M -151.25M -4.1222
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
466.86 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.28 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.55 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
596.13 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
306.88 31.54B 3.81B -644.79M -669.77M -6.24

Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-08 Iniziato Leerink Partners Outperform
2025-03-18 Iniziato Wolfe Research Outperform
2024-09-04 Iniziato Wedbush Outperform
2024-07-16 Iniziato Evercore ISI Outperform
2024-05-02 Iniziato Robert W. Baird Outperform
2024-03-01 Aggiornamento Wells Fargo Equal Weight → Overweight
2023-12-20 Iniziato BTIG Research Buy
2023-12-11 Iniziato Guggenheim Buy
2023-12-11 Iniziato Jefferies Buy
2020-05-04 Iniziato Piper Sandler Overweight
2019-03-21 Iniziato JP Morgan Overweight
2018-09-04 Downgrade Wells Fargo Outperform → Market Perform
2018-04-24 Iniziato Evercore ISI Outperform
2018-03-14 Reiterato Needham Buy
Mostra tutto

Spyre Therapeutics Inc Borsa (SYRE) Ultime notizie

pulisher
06:03 AM

Visual trend scoring systems applied to Spyre Therapeutics Inc.Trade Alert System with Volume Analysis - Newser

06:03 AM
pulisher
05:56 AM

Moving Average Trends for Spyre Therapeutics Inc. Stock: What They IndicateFree AI Screening for Swing Trade Picks - Newser

05:56 AM
pulisher
04:49 AM

Why Spyre Therapeutics Inc. stock attracts strong analyst attentionProven Trading System with Consistent Gains - Newser

04:49 AM
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Spyre Therapeutics Inc.Post Market Opportunities For Consistent Profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 18:29:12 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Market reaction to Spyre Therapeutics Inc.’s recent newsConservative Asset Allocation Risk Analysis - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Identifying reversal signals in Spyre Therapeutics Inc.RSI and MACD Signal Summary with Trends - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Victory Capital Management Inc. Sells 16,230 Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE) - Defense World

Jul 28, 2025
pulisher
Jul 28, 2025

How Resilient Is Spyre Therapeutics Inc. Stock During Economic Downturns AI Trading Forecast Based on Big Data - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Market reaction to Spyre Therapeutics Inc.’s recent news Free Quick Gain Stock Watch With Indicators - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How to track smart money flows in Spyre Therapeutics Inc. Free Low Volatility Stable Growth Picks - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

What makes Spyre Therapeutics Inc. stock price move sharplyGet real-time alerts on top stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Spyre Therapeutics Inc. stock compared to the marketExplosive trading growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Spyre Therapeutics Inc. compare to its industry peersInvest confidently with advanced analysis tools - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Resilient Is Spyre Therapeutics Inc. Stock During Economic DownturnsFree Exclusive Investment Tips - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Will Spyre Therapeutics Inc. stock benefit from AI tech trendsTriple-digit returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Is Spyre Therapeutics Inc. a good long term investmentHigh-impact stock picks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Spyre Therapeutics Inc. Stock Analysis and ForecastFree Investment Risk Control - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Spyre Therapeutics Inc. stockOutstanding capital growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

This Spyre Therapeutics Insider Reduced Their Stake By 55% - 富途牛牛

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Spyre Therapeutics Inc. stock priceRapid capital growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 20, 2025

Brokerages Set Spyre Therapeutics, Inc. (NASDAQ:SYRE) Target Price at $53.40 - Defense World

Jul 20, 2025
pulisher
Jul 15, 2025

How Spyre Therapeutics Inc. stock performs during market volatilityPredictable High Return Trades - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Here's Why We're Not Too Worried About Spyre Therapeutics' (NASDAQ:SYRE) Cash Burn Situation - Yahoo Finance

Jul 15, 2025

Spyre Therapeutics Inc Azioni (SYRE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$76.97
price up icon 9.66%
$37.42
price up icon 0.93%
$103.61
price up icon 1.81%
$27.05
price down icon 1.38%
$110.37
price down icon 2.17%
biotechnology ONC
$306.88
price up icon 4.22%
Capitalizzazione:     |  Volume (24 ore):